Punch Skin Biopsy Clinical Trial
— CICATOfficial title:
Immediate Suture or Directed Wound Healing? Comparative Study of Their Respective Values Following a Punch Skin Biopsy (CICAT)
The skin punch-biopsies are frequently used technical acts in the current medical practice. However, while these skills are actually easy to perform, the subsequent healing procedure remains still poorly harmonized. Indeed, it usually depends on the physicians personal experiences and some preconceived considerations without any reliable scientific background. This study aims to explore the performances of a directed wound healing behaviour in comparison with the suture.
| Status | Recruiting |
| Enrollment | 400 |
| Est. completion date | November 2022 |
| Est. primary completion date | November 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - adult person (age greater than or equal to 18 years) - either hospitalized patient in a conventional or in a day care department, either seen at a medical appointment in Le Mans General Hospital - person on whom the indication of one or several skin biopsy(ies) using a punch of 4 mm diameter has been established - affiliated or beneficiary of a statutory social insurance scheme - free and informed written consent, signed by both the participant and the investigator (the day of inclusion at the latest and prior to any examination needed by the protocol) after an oral and written information Exclusion Criteria: - skin biopsy on the face or the cervical area - pregnant, breastfeeding or parturient woman - person deprived of liberty by an administrative act or a court decision - patient requiring compulsory mental health care - minor or legally protected adult - patient that is no longer in a condition to express his or her wishes - person that have participated or that are taking part in an interventional study over the past 30 days (condition of exclusivity) |
| Country | Name | City | State |
|---|---|---|---|
| France | Centre Hospitalier Du Mans | Le Mans |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier le Mans |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Assess aesthetic quality of the scar by physician | the asserted aesthetic quality of the scar will be assessed by a dermatologist with 4-level scale | one month after skin punch biopsy | |
| Secondary | Assess aesthetic quality of the scar by patient | The asserted aesthetic quality of the scar will be assessed by the participant himself using a 4-level scale | 1 month after skin biopsy punch | |
| Secondary | Assess maximal pain experienced by the patient | The maximal pain experienced by the patient during the Healing phase will be assessed with a numerical scale ranging from 0 to 10 | 1 month after skin biopsy punch | |
| Secondary | Assess amount of bleeding | the scoring of the amount of bleeding subsequent to the skin biopsy will be assessed with a numerical scale ranging from 0 to 10 | immediately after skin biopsy punch | |
| Secondary | Assess clotting time | The clotting time subsequent to the skin biopsy will be assessed using a 4-level scale | immediately after skin biopsy punch | |
| Secondary | Observe cutaneous infection | occurrence of a cutaneous infection that had required an antibiotic treatment and/or the achievement of a drainage during the month following the skin punch-biopsy | 1 month after skin biopsy punch |